Neurochemistry International
November 19, 2025
Zhaoliang Gu, Ruixue Song, Guoqiang Liu et al.
3 citations
Post-traumatic stress disorder (PTSD) is a chronic psychological disorder that is induced by traumatic events. The pathophysiological mechanism of PTSD involves complex neurobiological processes. However, the underlying mechanism is not clear, leading to lack of effective therapeutic interventions. Mice were exposed to the electric foot shocks using the contextual fear memory paradigm. A...
Molecular Psychiatry
November 18, 2025
A. Arena, M. R. Rubinstein, A. M. Genaro et al.
Ketamine has emerged as a rapid and sustained treatment for Major Depressive Disorder (MDD) and an alternative for patients who have not responded to traditional therapies. Its effects have been partly attributed to the noncompetitive antagonism of the N-methyl-D-aspartate receptor (NMDAR) in the central nervous system, which enhances neuroplasticity. However, the etiopathology of MDD is...
Research Square
November 18, 2025
Guy W. Fincham, Edward Caddye, Amy Kartar et al.
preprint
Abstract Breathwork which increases ventilatory rate or depth represents an accessible nonpharmacological modality for potentially inducing altered states of consciousness (ASCs). Despite gaining traction as a therapeutic tool, empirical research remains limited, hence we conducted the first randomised-controlled trial (NCT06916312) on breathwork and ASCs. We examined the effects of a single...
BMC Psychology
November 16, 2025
Tayebeh Rakhshani, Afrooz Bagherfard, Amirhossein Kamyab et al.
1 citation
Abstract Background Women’s increasing workforce participation has led to stress, anxiety, and strained parent-child relationships, highlighting the need for effective interventions. Mindfulness-based stress reduction (MBSR) is a promising yet underutilized approach to improving psychological well-being and parenting quality. This study examines its impact on self-compassion and parent-child...
Psychedelics
November 15, 2025
Meghan DellaCrosse, Shoval Gilead, Rafael Lancelotta et al.
Serotonergic psychedelics like psilocybin and LSD have shown potential therapeutic benefits for mental health conditions, including depression, PTSD, and addiction. However, research remains limited due to regulatory barriers and a lack of diversity in study populations. Spanish-speaking individuals, despite their significant global and U.S. presence, are underrepresented in psychedelic...
Psychopharmacology
November 15, 2025
Elisabetta Ciccocioppo, Sara Massetti, Marcus W. Meinhardt et al.
Alcohol use disorder (AUD) represents a significant medical challenge, with available therapeutic approaches having limited efficacy. Emerging data suggest that psychedelic compounds could represent an alternative treatment for AUD. Among this class of molecules, ketamine, a dissociative psychedelic, shows promising properties. It reduces alcohol drinking in rodents and in humans it is used to...
Molecular Psychiatry
November 14, 2025
Núria Nadal‐gratacós, Pol Puigseslloses, Laura Hernández‐guzmán et al.
Psychedelics have garnered significant interest for their therapeutic potential in mental health conditions such as depression, anxiety, and post-traumatic stress disorder. While research has primarily focused on well-studied psychedelics, phenethylamine derivatives have also gathered interest for their potential therapeutic applications. Thus, this study aims to investigate the pharmacological...
Psychiatry and Clinical Psychopharmacology
November 13, 2025
Yimeng Ma, Zhiguo Ge, Xinyan Wu
Background: Buspirone shows a certain efficacy in patients with generalized anxiety disorder (GAD), but its combination therapy with mindfulness-based cognitive therapy (MBCT) remains unclear. To compare buspirone + MBCT versus buspirone alone for GAD in a retrospective cohort. Methods: According to the treatment regimens, patients were assigned to the experimental group (n = 50) to receive 120...
Berkeley Scientific Journal
November 13, 2025
Ana Sofia Brito
Interview with Dr. Andrea Gomez
Indian Journal of Psychological Medicine
November 13, 2025
Malika M Sanspara, Drashti M Shah, Sandip H Shah et al.
This study evaluated intramuscular (IM) ketamine's efficacy and safety for rapid suicidal ideation reduction, addressing the critical need for fast-acting interventions in resource-limited settings where intravenous (IV) options are impractical. We conducted a pre-post-interventional study of IM ketamine (0.5 mg/kg) over one year after approval of the institutional ethics committee. Adult...